Related references
Note: Only part of the references are listed.Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it
Yuanyuan Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Sex Hormones and Prostate Cancer
Richard J. Auchus et al.
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
Metabolomic profiling to evaluate the efficacy of proxalutamide, a novel androgen receptor antagonist, in prostate cancer cells
Feng Qu et al.
INVESTIGATIONAL NEW DRUGS (2020)
Citral Induced Apoptosis through Modulation of Key Genes Involved in Fatty Acid Biosynthesis in Human Prostate Cancer Cells: In Silico and In Vitro Study
Sri Renukadevi Balusamy et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Emerging Therapeutic Activity of Davallia formosana on Prostate Cancer Cells through Coordinated Blockade of Lipogenesis and Androgen Receptor Expression
Po-Fan Hsieh et al.
CANCERS (2020)
Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer
Tie Zhou et al.
EUROPEAN JOURNAL OF CANCER (2020)
The role of the androgen receptor in prostate cancer-induced platelet aggregation and platelet-induced invasion
Jan K. Rudzinski et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer
Daisuke Obinata et al.
FRONTIERS IN ONCOLOGY (2020)
Modulation of de Novo Lipogenesis Improves Response to Enzalutamide Treatment in Prostate Cancer
Mohamed Amine Lounis et al.
CANCERS (2020)
Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis
Kaylyn D. Tousignant et al.
MOLECULAR CANCER RESEARCH (2019)
Novel steroidal 1,3,4-thiadiazines: Synthesis and biological evaluation in androgen receptor-positive prostate cancer 22Rv1 cells
Anna S. Komendantova et al.
BIOORGANIC CHEMISTRY (2019)
Osajin displays potential antiprostate cancer efficacy via impairment of fatty acid synthase and androgen receptor expression
Shih-Yin Huang et al.
PROSTATE (2019)
CRISPR/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cells
Sina Rahimi et al.
LIFE SCIENCES (2019)
Global incidence of prostate cancer in developing and developed countries with changing age structures
Jeremy Y. C. Teoh et al.
PLOS ONE (2019)
Fatty Acid Inhibition Sensitizes Androgen-Dependent and -Independent Prostate Cancer to Radiotherapy via FASN/NF-κB Pathway
Hui-Yen Chuang et al.
SCIENTIFIC REPORTS (2019)
Perspectives on the current and emerging chemical androgen receptor antagonists for the treatment of prostate cancer
Athanasios E. Dellis et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism
Krishna B. Singh et al.
CARCINOGENESIS (2018)
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer
David Y. Takeda et al.
CELL (2018)
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism
Carlotta Granchi
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC)
Yifan Kong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Ganoderma tsugae Inhibits the SREBP-1/AR Axis Leading to Suppression of Cell Growth and Activation of Apoptosis in Prostate Cancer Cells
Shih-Yin Huang et al.
MOLECULES (2018)
The Metabolic Phenotype of Prostate Cancer
Eric Eidelman et al.
FRONTIERS IN ONCOLOGY (2017)
Fatty Acid Synthesis Intermediates Represent Novel Noninvasive Biomarkers of Prostate Cancer Chemoprevention by Phenethyl Isothiocyanate
Krishna B. Singh et al.
CANCER PREVENTION RESEARCH (2017)
Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting
E. S. Antonarakis et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Diagnostic and Therapeutic Strategies for Prostate Cancer
Mary Nguyen-Nielsen et al.
SEMINARS IN NUCLEAR MEDICINE (2016)
Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells
Martuza Sarwar et al.
ONCOTARGET (2016)
miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer
Mei Xin et al.
ONCOTARGET (2016)
P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth
Xiaokun Gang et al.
ONCOTARGET (2016)
Aberrant Lipid Metabolism Promotes Prostate Cancer: Role in Cell Survival under Hypoxia and Extracellular Vesicles Biogenesis
Gagan Deep et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Reconsideration of progression to CRPC during androgen deprivation therapy
Atsushi Mizokami et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Androgen receptor signaling in prostate cancer
Zoran Culig et al.
CANCER AND METASTASIS REVIEWS (2014)
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity
Chiara Fiorentini et al.
EXPERIMENTAL CELL RESEARCH (2014)
Fatostatin Displays High Antitumor Activity in Prostate Cancer by Blocking SREBP-Regulated Metabolic Pathways and Androgen Receptor Signaling
Xiangyan Li et al.
MOLECULAR CANCER THERAPEUTICS (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis
X. Yuan et al.
ONCOGENE (2014)
The fat side of prostate cancer
Giorgia Zadra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Progress in emerging therapies for advanced prostate cancer
Stephane Oudard
CANCER TREATMENT REVIEWS (2013)
Androgen receptors in hormone-dependent and castration-resistant prostate cancer
Ayesha A. Shafi et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Cholesterol and prostate cancer
Kristine Pelton et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
Charles E. Massie et al.
EMBO JOURNAL (2011)
The Effects of Androgen Deprivation Therapy on Lipid Metabolism and Body Composition in Japanese Patients with Prostate Cancer
Kazumasa Torimoto et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2011)
Drug resistance in metastatic castration-resistant prostate cancer
Bostjan Seruga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases
Xiaotun Zhang et al.
PLOS ONE (2011)
De novo Lipogenesis Protects Cancer Cells from Free Radicals and Chemotherapeutics by Promoting Membrane Lipid Saturation
Evelien Rysman et al.
CANCER RESEARCH (2010)
Fatty acid synthase as a potential therapeutic target in cancer
Richard Flavin et al.
FUTURE ONCOLOGY (2010)
Molecular genetics of prostate cancer: new prospects for old challenges
Michael M. Shen et al.
GENES & DEVELOPMENT (2010)
Molecular mechanisms of castration-resistant prostate cancer progression
Smitha S. Dutt et al.
FUTURE ONCOLOGY (2009)
Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3
Shu-Fen Kan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Androgen deprivation therapy for prostate cancer
N Sharifi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Primary tumor-derived TGF-B1 induces dendritic cell apoptosis in sentinel lymph nodes of patients with non-small cell lung cancer
M Ito et al.
LUNG CANCER (2005)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes
H Shimano
PROGRESS IN LIPID RESEARCH (2001)
Coupling endoplasmic reticulum stress to the cell death program - Mechanism of caspase activation
RV Rao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
